scholarly journals Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.

BMJ ◽  
1993 ◽  
Vol 307 (6907) ◽  
pp. 764-769 ◽  
Author(s):  
K Spencer ◽  
P Carpenter
Author(s):  
D E Wright ◽  
T M Reynolds ◽  
C M Donovan

Current software used for assessment of the risk of Down's syndrome may give misleading risk estimates if applied to other abnormalities. Often the abnormality is reflected in maternal serum α-fetoprotein and human chorionic gonadotrophin levels and is then translated into a low risk for Down's syndrome that may not be recognized as significantly atypical of normality. We regard this as a serious deficiency in the current Down's syndrome risk reporting algorithm, and suggest a modification that allows the problem to be overcome.


Sign in / Sign up

Export Citation Format

Share Document